Atlas Trials

A Study of Bevacizumab, Carboplatin, and Paclitaxel or Pemetrexed With or Without Atezolizumab in Chemotherapy-Naïve Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer (IMpower151)

Clinical trial NCT04194203 · COMPLETED

Trial details

NCT number
NCT04194203
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Carcinoma, Non-Small-Cell Lung
Start date
2020-04-09
Primary completion
2023-02-02
Enrollment
305

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.